Ad is loading...
APLS
Price
$30.08
Change
+$2.33 (+8.40%)
Updated
Nov 22, 03:14 PM (EDT)
102 days until earnings call
IMVT
Price
$26.81
Change
+$0.27 (+1.02%)
Updated
Nov 22, 03:22 PM (EDT)
82 days until earnings call
Ad is loading...

APLS vs IMVT

Header iconAPLS vs IMVT Comparison
Open Charts APLS vs IMVTBanner chart's image
Apellis Pharmaceuticals
Price$30.08
Change+$2.33 (+8.40%)
Volume$185
CapitalizationN/A
Immunovant
Price$26.81
Change+$0.27 (+1.02%)
Volume$1.21K
CapitalizationN/A
APLS vs IMVT Comparison Chart
Loading...
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
APLS vs. IMVT commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and IMVT is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (APLS: $27.75 vs. IMVT: $26.54)
Brand notoriety: APLS and IMVT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 44% vs. IMVT: 78%
Market capitalization -- APLS: $3.45B vs. IMVT: $3.84B
APLS [@Biotechnology] is valued at $3.45B. IMVT’s [@Biotechnology] market capitalization is $3.84B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileIMVT’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • IMVT’s FA Score: 0 green, 5 red.
According to our system of comparison, IMVT is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 4 TA indicator(s) are bullish while IMVT’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 4 bullish, 4 bearish.
  • IMVT’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both APLS and IMVT are a good buy in the short-term.

Price Growth

APLS (@Biotechnology) experienced а -1.10% price change this week, while IMVT (@Biotechnology) price change was -5.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.14%. For the same industry, the average monthly price growth was -4.98%, and the average quarterly price growth was +4.01%.

Reported Earning Dates

APLS is expected to report earnings on Mar 04, 2025.

IMVT is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Biotechnology (+2.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMVT($3.84B) has a higher market cap than APLS($3.45B). IMVT YTD gains are higher at: -37.005 vs. APLS (-53.642). APLS has higher annual earnings (EBITDA): -209.71M vs. IMVT (-352.16M). IMVT has more cash in the bank: 473M vs. APLS (397M). IMVT has less debt than APLS: IMVT (47K) vs APLS (470M). APLS has higher revenues than IMVT: APLS (715M) vs IMVT (0).
APLSIMVTAPLS / IMVT
Capitalization3.45B3.84B90%
EBITDA-209.71M-352.16M60%
Gain YTD-53.642-37.005145%
P/E RatioN/AN/A-
Revenue715M0-
Total Cash397M473M84%
Total Debt470M47K1,000,000%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSIMVT
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IMVT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VMIAX106.641.35
+1.28%
Vanguard Materials Index Admiral
MLVOX21.910.25
+1.15%
MFS Low Volatility Equity R2
RGAVX13.090.09
+0.69%
ClearBridge Global Infrastructure Inc A
RGGRX18.400.10
+0.55%
Victory RS Global R6
GAFFX81.370.07
+0.09%
American Funds Growth Fund of Amer F3

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with ZYME. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then ZYME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
+0.95%
ZYME - APLS
39%
Loosely correlated
-5.98%
PGEN - APLS
38%
Loosely correlated
+7.91%
BCRX - APLS
36%
Loosely correlated
+2.60%
INZY - APLS
35%
Loosely correlated
-3.58%
IMVT - APLS
35%
Loosely correlated
+1.41%
More

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+1.41%
ROIV - IMVT
58%
Loosely correlated
+2.87%
BRNS - IMVT
48%
Loosely correlated
+9.93%
RVMD - IMVT
42%
Loosely correlated
-0.51%
SNDX - IMVT
39%
Loosely correlated
-2.19%
ARGX - IMVT
37%
Loosely correlated
+0.83%
More